Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04623801 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Laser Ablation of Papillary Thyroid Microcarcinoma

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv11
  2. Primary and study completion dates: Oct 2025 to Oct 2026v10
  3. Re-verified, no change to tracked fieldsv9
  4. Trial status: Recruiting to Active, Not Recruiting Site details revisedv8 Show 1 more changeShow less
    • Site details revised
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: Oct 2023 to Oct 2025v6
  2. Primary and study completion dates: Oct 2022 to Oct 2023v5
  3. Eligibility criteria expanded, about 63 wordsv4 See this version in full on ClinicalTrials.gov ↗
  4. Eligibility criteria shortened, about 35 wordsv3 See this version in full on ClinicalTrials.gov ↗
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.
Trial Details
NCT Number NCT04623801
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Papillary Thyroid Microcarcinoma, Thyroid, Thyroid Cancer
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov